News
180 Life Sciences stock tumbles after announcing $500 million share sale
The biopharmaceutical company disclosed on August 13, 2025, that it had established an "at-the-market" offering program with Clear Street LLC acting as sales agent. Under the agreement, 180 Life Sciences will be able to sell shares from time to time, with the sales occurring either in negotiated transactions or as part of an at-the-market offering.
ETHZILLA (180 Life Sciences) pivots to an Ethereum treasury strategy, holding 82,186 ETH. Stock surged 312% in a year. Learn ...
Under the agreement, Clear Street is entitled to up to 3% of the gross sales price per share of all 180 Life Sciences shares that are sold. The biotechnology company has additionally agreed to ...
AMD (AMD) stock is jumping to its highest level since July, days after the company made a deal with the White House on ...
Life Sciences Corp. rebrands to ETHZilla, pivots to Ethereum treasury with 82K ETH holdings. Click for my take on ATNF stock following these developments.
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the ...
U.S. stock futures were fluctuating on Friday following Thursday’s mixed moves. Futures of major benchmark indices were mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback